Lucid Diagnostics Inc.
Net SellingLUCD·US·🇺🇸 US
40%buys·60%sells
65 transactions$9.0MTotal buys·8 buys
$113KTotal sells·12 sells
1313 insiders
Last: Oct 6, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Oct 6, 25 | PALUMBO JOHN R | Grant | - | |
| Aug 20, 25 | Matheis Dennis | Buy | $102K | |
| May 22, 25 | Matheis Dennis | Buy | $44K | |
| May 22, 25 | Matheis Dennis | Buy | $44K | |
| May 21, 25 | Matheis Dennis | Buy | $171K | |
| May 21, 25 | Matheis Dennis | Buy | $171K | |
| May 20, 25 | Matheis Dennis | Buy | $243K | |
| May 20, 25 | Matheis Dennis | Buy | $243K | |
| Feb 20, 25 | Sparks Ronald M | Grant | - | |
| Feb 20, 25 | White Debra | Grant | - |
Lucid Diagnostics Inc. (LUCD) has recorded 65 insider transactions from 13 insiders. Total insider buying volume stands at $9.0M, while total selling volume is $113K. Overall insider sentiment is bearish (60% sales).
Lucid Diagnostics Inc. (LUCD) has recorded 65 insider operations, including 8 open-market purchases ($9.0M), 12 sales ($113K) and 45 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (60% sales).
Lucid Diagnostics Inc. shows moderate insider activity with 4 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Aklog Lishan (CEO), MCGRATH DENNIS M (CFO) & SOKOLOV JACQUE J (BOARD MEMBER), with respectively 151, 105, 44 transactions.
Across all 65 recorded transactions, the breakdown by type is: grant (38, 58%), sells (12, 18%), buys (8, 12%), other (7, 11%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Lucid Diagnostics Inc. has recorded 65 insider operations in total, including 8 open-market purchases ($9.0M), 12 sales ($113K) and 45 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on October 6, 2025.
Insiders at Lucid Diagnostics Inc. are currently net sellers, with 40% purchases and 60% sales across all reported transactions. Total buy volume is $9.0M versus $113K in sales, indicating a bearish insider sentiment.
InsiderLens tracks 13 insiders at Lucid Diagnostics Inc. (LUCD). Aklog Lishan (CEO, 151 tx), MCGRATH DENNIS M (CFO, 105 tx), SOKOLOV JACQUE J (BOARD MEMBER, 44 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for LUCD is bearish, based on a 40% buy ratio across 20 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Lucid Diagnostics Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.